-
Streptavidin – Cy5 Workflows for USP42 Research
2026-09-11
Connect biotinylated antibodies, nucleic acids, and proteins to sensitive Cy5 fluorescence across immunofluorescence, IHC, ISH, and flow cytometry. This practical guide translates the USP42 breast cancer findings into controlled detection workflows, assay controls, and troubleshooting decisions.
-
a-MSH, amide Workflows for Melanogenesis Research
2026-09-11
Build controlled melanocortin stimulation assays with a-MSH, amide to quantify melanin production, receptor-linked signaling, and candidate inhibitor performance. The workflow combines pigmentation endpoints with viability and inflammatory readouts, helping distinguish genuine melanin synthesis modulation from nonspecific toxicity or formulation artifacts.
-
GRE Composition Inhibits Melanogenesis via CREB/MITF
2026-09-10
A 2025 study found that combining glabridin, resveratrol, and ellagic acid produced the strongest overall anti-melanogenic, antioxidant, and anti-inflammatory activity among the tested conditions. Its mechanistic data connect reduced CREB phosphorylation with suppression of MITF-associated pigmentation signaling, while the cellular assays define a useful framework for evaluating combination-based melanin synthesis modulation.
-
ONX-0914 (PR-957) in Immune and Neural Assays
2026-09-10
ONX-0914 (PR-957) combines selective LMP7 targeting with a workflow that can separate cytokine biology from broader proteasome effects. Beyond autoimmune and inflammatory models, the reference study shows how chronic exposure can be paired with hippocampal electrophysiology and gene-expression analysis to resolve context-specific outcomes.
-
Psora 4: Practical Kv1.3 Assay Workflows
2026-09-09
Psora 4 enables mechanism-focused studies of Kv1.3-dependent membrane potential, calcium entry, and effector-memory T-cell responses. This guide connects compound handling with cell-state controls, kinetic pharmacology, and translational use in inflammatory disease models.
-
Catalpol, Osteoclast Apoptosis, and Osteoporosis
2026-09-09
This study identifies the Sirt6–ERα–FasL axis as a mechanistic link between catalpol treatment and osteoclast apoptosis in ovariectomized rats. Its combination of micro-CT, cellular assays, protein analysis, and Sirt6 knockdown provides a useful framework for evaluating natural products in postmenopausal osteoporosis research.
-
Radicicol Workflows for Hsp90 Inhibition
2026-09-08
Radicicol supports controlled studies of Hsp90-dependent cell fate, adipocyte differentiation, ovarian carcinoma apoptosis, kinase biology, and inflammatory phenotypes. This practical guide connects product-specific handling with assay design, dose selection, and the mitochondrial-senescence framework highlighted in recent periodontal stem-cell research.
-
Premature Stimulation Expands Atrial Slow Conduction
2026-09-08
This study shows that premature stimulation enlarges pre-existing slow-conduction regions in the atria of goats with persistent atrial fibrillation, rather than simply creating new regions. Its optical-mapping framework links pacing conditions to dynamic spatial changes in conduction, providing a useful model for studying how arrhythmogenic substrate is revealed during short-coupled activation.
-
AM 281 and the CB1–CREB–GLT-1 Axis
2026-09-07
AM 281 provides a selective pharmacological lens for studying how CB1 signaling, astrocytic GLT-1 regulation, and CREB activity converge on cognitive dysfunction after traumatic brain injury. This thought-leadership guide translates recent mouse findings into practical assay strategy, translational guardrails, and a clearer framework for memory impairment research.
-
Homoharringtonine: From Mechanism to Translation
2026-09-07
Homoharringtonine illustrates how a cytotoxic alkaloid can serve as both a mechanistic probe in leukemia research and a translational starting point for SARS-CoV-2 antiviral research. This thought-leadership analysis connects ribosome-level biology with experimental design, evidence appraisal, and responsible research strategy.
-
Recombinant Human Oncostatin M Workflow Guide
2026-09-05
Build reproducible OSM dose–response, proliferation, and cytokine-release assays with a tag-free, high-purity cytokine format. This guide also shows how to translate the NLRP3–astrocyte findings of a recent morphine-tolerance study into disciplined, hypothesis-generating assay designs without overstating the evidence.
-
Ceftazidime Workflows for Resistance Research
2026-09-04
Build reproducible susceptibility, time-kill, and resistance-surveillance workflows with Ceftazidime, a third-generation cephalosporin that is especially useful for Gram-negative and Pseudomonas-focused assays. The workflow also shows how to avoid confusing standalone Ceftazidime activity with ceftazidime/avibactam results in carbapenem-resistant Enterobacter studies.
-
BCA Protein Quantification Kit: Practical Guide
2026-09-04
The BCA Protein Quantification Kit K4102 supports sensitive total-protein measurement for dilute samples, cell lysates, and many detergent-containing biochemical preparations. It is intended for scientific research workflows and should not be used for diagnostic, clinical, or medical testing.
-
Azilsartan: From AT1 Blockade to Translation
2026-09-03
Azilsartan (TAK-536) offers a precise pharmacological entry point for testing how AT1 signaling connects the renin–angiotensin system with astrocyte reactivity, microglial communication, inflammation, and cardiovascular biology. This thought-leadership guide translates recent mechanistic findings into stronger experimental designs and more disciplined translational interpretation.
-
NSC 87877: A Causal SHP2 Assay Strategy
2026-09-03
NSC 87877 is a potent Shp2 inhibitor for testing whether SHP2-dependent phosphatase activity causally shapes neuroinflammatory signaling. This article translates ischemic-stroke findings into a rigorous assay framework while addressing selectivity, timing, controls, and cross-model limitations.